CB₂ Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Agriculture & Biology

• Human immunodeficiency virus 1 70%
• agonists 53%
• neuroglia 50%
• neurons 47%
• receptors 38%
• cannabinoids 30%
• astrocytes 13%
• therapeutics 13%
• dopamine 11%
• neuroprotective effect 7%
• chemokines 7%
• cell movement 6%
• cytokines 5%
• superoxide anion 5%
• apoptosis 5%
• transporters 4%
• lipid peroxidation 4%
• death 4%
• viability 4%
• brain 4%
• uptake mechanisms 3%
• testing 2%
• proteins 1%

Medicine & Life Sciences

• Cannabinoid Receptor CB2 81%
• Dopaminergic Neurons 60%
• HIV-1 50%
• Microglia 29%
• Cannabinoids 26%
• Neurocognitive Disorders 15%
• Neuroglia 15%
• Astrocytes 10%
• Human Immunodeficiency Virus Proteins 7%
• Dopamine Plasma Membrane Transport Proteins 7%
• Neurologic Manifestations 5%
• Superoxides 5%
• Chemokines 5%
• Lipid Peroxidation 5%
• Dopamine 4%
• Acquired Immunodeficiency Syndrome 4%
• Cell Movement 4%
• Poisons 4%
• Cytokines 3%
• Apoptosis 3%
• Therapeutics 2%
• Brain 2%

Chemical Compounds

• Cannabinoid 2 Receptor Agonist 100%
• Dopamine 36%
• Disorder 32%
• Antiretroviral 27%
• Neuroprotective 24%
• Cannabinoid 24%
• Superoxide 18%
• Toxic 14%
• Lipid 13%
• Protein 7%